Clinical Trials Directory

Trials / Completed

CompletedNCT01767298

Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)

Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, Four-Period Crossover Study in Healthy Egyptian Male Volunteers (PART II)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Damanhour University · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study was conducted to compare the rate and extent of absorption of valsartan and hydrochlorothiazide. To maximize the possibility of finding drug-drug interactions, the dose of valsartan and hydrochlorothiazide was doubled (320 mg of VAL and 25 mg of HCT).

Conditions

Interventions

TypeNameDescription
DRUGValsartan/HydrochlorothiazideCo-administration or fixed dose combination
DRUGValsartanValsartan alone
DRUGHydrochlorothiazideHydrochlorothiazide alone

Timeline

Start date
2012-10-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2013-01-14
Last updated
2013-01-14

Source: ClinicalTrials.gov record NCT01767298. Inclusion in this directory is not an endorsement.

Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses) (NCT01767298) · Clinical Trials Directory